INTL Overview

• Stock Sale Announcement: Sean O'Connor, an officer at StoneX, plans to sell 40,000 shares of its common stock on February 10, with a market value of approximately $4.95 million.

• Reduction in Shareholding: O'Connor has reduced his shareholding in StoneX by 40,000 shares since February 9, 2026, with a total value of around $5 million.

• Economic Indicators and Federal Reserve Outlook: July's inflation data showed mixed results, with the consumer price index steady at 2.7% year-over-year while the Producer Price Index rose sharply by 0.9%, complicating the Federal Reserve's decision on potential rate cuts, which investors still expect to be around 25 basis points in September.

• Stock Market Highlights: Intel's stock surged over 25% following speculation of a U.S. government stake linked to the CHIPS Act, marking its best week since 2000, while other notable movements included bullish positions in UnitedHealth by prominent investors and bearish trends for companies like Rigetti Computing and Coherent Corp after disappointing earnings reports.

• Intel's Disappointing Guidance: Intel Corp shares fell sharply after the company provided disappointing second-quarter revenue guidance of $11.8 billion, missing analyst expectations of $12.8 billion, amid concerns over demand due to potential tariffs and an uncertain economic landscape.

• Analyst Ratings and Concerns: Various analysts maintained or adjusted their ratings on Intel, with some expressing skepticism about the company's ability to improve its competitive position in the face of stiff competition and ongoing tariff-related challenges affecting future growth.

• M4 Chip Integration: Apple is set to integrate the new M4 processor into its Mac lineup, enhancing AI and gaming performance with increased core counts. New models expected include a 24-inch iMac, revamped Mac mini, and updated MacBook Pro versions.

• Future Plans: The M4 chip will also be introduced in the MacBook Air, Mac Studio, and Mac Pro by early 2025, following its previous launch in the iPad Pro, where it was noted for its superior processing capabilities.

• Crypto Market Analysis: Andrew Kang compares Ethereum to tech stocks, noting similarities in price action with May 2021.
• Market Caution: Despite bullish momentum, Kang warns of potential extreme corrections over a multi-month period.
• Skepticism on Support Levels: Kang expresses doubt about support levels holding amidst market disruptions like Mt Gox estate selling and ETF buyers selling.
• Comparison to Tech Companies: Kang draws parallels between Ethereum's valuation and growth prospects to past tech bubbles rather than sustained growth seen in companies like NVIDIA and Amazon.
• Ethereum's Fundamentals: Kang questions Ethereum's high valuation based on negative revenue growth, profitability, and declining interest in NFTs.

Smaller health care stocks have been undervalued, says Main Management exec.

"We have an overweight position there — not only in the major pharmaceuticals sector, but also the smaller biotechs."